Page last updated: 2024-10-31

midazolam and Parodontosis

midazolam has been researched along with Parodontosis in 2 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Staretz, LR1
Otomo-Corgel, J1
Lin, JI1
Valentin, AH1
Foitzik, C1

Trials

1 trial available for midazolam and Parodontosis

ArticleYear
Effects of intravenous midazolam and diazepam on patient response, percentage of oxygen saturation, and hemodynamic factors during periodontal surgery.
    Journal of periodontology, 2004, Volume: 75, Issue:10

    Topics: Adult; Aged; Anesthesia Recovery Period; Anesthesia, Dental; Blood Pressure; Conscious Sedation; Cro

2004

Other Studies

1 other study available for midazolam and Parodontosis

ArticleYear
[Concepts for periodontal treatment for mentally retarded children].
    Die Quintessenz, 1989, Volume: 40, Issue:11

    Topics: Anesthesia, Dental; Appointments and Schedules; Child; Dental Care for Disabled; Humans; Intellectua

1989